The offering at Schellenberg Wittmer Ltd covers a varied workload, with a strong emphasis on M&A, spin-offs, and product liability disputes. The team is also recommended for assisting with allegations of abuse of dominant position and private equity transactions within the healthcare space. Practice co-head Philipp Groz is particularly adept at handling international arbitrations concerning distribution, development, and supply agreements, often representing pharma companies; Groz is also noted for his regulatory expertise in mobile health apps. ‘Top notch IP practitioner’ Lorenza Ferrari Hofer co-leads the team, and is recommended for her strong focus on cross-border licensing and distribution issues relating to tech and health products, in addition to acting in trade secret and patent infringement disputes. Peter Georg Picht’s area of expertise lies at the intersection between IP and competition law on a domestic and European level.

Legal 500 Editorial commentary

Testimonials

Collated independently by Legal 500 research team.

  • 'Lorenza Ferrari is a top notch IP practitioner - reliable, efficient and pragmatic. A powerful do-er including in international associations such as the IBA.'

Key clients

  • AbbVie
  • Addlife AB
  • Bayer AG
  • BioNTech
  • Zimmer Biomet
  • AOP Orphan Pharmaceuticals AG
  • Ascensia Diabetes Care
  • Cardinal Health
  • Celgene
  • CSL Behring AG
  • Johnson & Johnson
  • Kinarus
  • LivaNova
  • Procter & Gamble
  • Shire International GmbH
  • Sonova
  • Iveric Bio
  • Santhera Pharmaceuticals
  • ZimVie
  • Dandelion
  • Asker Healthcare Group
  • Novartis
  • Sosei Group
  • Gilde Healthcare Partners BV
  • BridgeBio International

Work highlights

  • Advised Swiss company Santhera Pharmaceuticals regarding the sale of its Raxone/idebenone business to Chiesi.
  • Advised the Sosei Group on the acquisition of all shares of Idorsia Pharmaceuticals Japan Ltd and Idorsia Pharmaceuticals Korea Co., Ltd.
  • Acted in an arbitration between a university spin-off and a multinational medical device manufacturer regarding worldwide royalties allegedly owed under a series of licensing agreements.

Lawyers

Leading partners
The strongest partners in their field, leading on market-leading deals and endorsed by peers and clients alike.

Practice head

The lawyer(s) leading their teams.

Philipp Groz, Lorenza Ferrari Hofer

Other key lawyers

Pascal Hubli, Stéphanie Chuffart-Finsterwald, Peter Georg Picht